Related Experiment Video
Updated: Jul 24, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.1K
Immunotherapy using Histobulin™ in psoriasis: A case report
Hyuk Soon Kim1, Geunwoong Noh2
1Department of Biomedical Sciences College of Natural Science and Department of Health Sciences The Graduate School of Dong-A University Busan Korea.
Clinical Case Reports
|May 20, 2022
Summary
Histobulin™ shows promise as a curative therapy for psoriasis, effectively clearing patient symptoms for over 18 months. This novel treatment offers hope for long-term psoriasis remission.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Psoriasis is a chronic autoimmune condition with no current cure.
- Existing treatments aim to manage symptoms and inflammation.
Observation:
- A single patient with psoriasis was administered Histobulin™.
- Treatment involved multiple injections over a period of time.
Findings:
- Complete resolution of clinical psoriasis symptoms and signs was observed after eight injections.
- Symptomatic relief persisted for over 18 months post-treatment, indicating sustained efficacy.
- Histobulin™ demonstrated significant therapeutic effectiveness in this psoriasis case.
Implications:
- Histobulin™ presents a potential curative therapeutic option for psoriasis.
- Further clinical trials are warranted to validate these findings in a larger patient cohort.
- This research could lead to a breakthrough in psoriasis management and treatment paradigms.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

